Residual Disease Detection by Flow Cytometry Predicts Risk of Relapse and Overall Survival in Patients with Acute Myeloid Leukemia Following Reduced Intensity- and Myeloablative- Allogeneic Hematopoietic Cell Transplantation

Схожі ресурси

• Residual Disease Detection by Flow Cytometry Predicts Risk of Relapse and Overall Survival in Patients with Acute Myeloid Leukemia Following Reduced Intensity- and Myeloablative-Allogeneic Hematopoietic Cell Transplantation
  за авторством: Bradbury, C, та інші
  Опубліковано: (2012)
• Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia.
  за авторством: Vyas, P, та інші
  Опубліковано: (2015)
• Preliminary results of an non-myeloablative conditioning regimen for allogeneic stem cell transplantation.
  за авторством: Mackinnon, S, та інші
  Опубліковано: (1999)
• An operational definition of primary refractory acute myeloid leukemia allowing early identification of patients who may benefit from allogeneic stem cell transplantation
  за авторством: Ferguson, P, та інші
  Опубліковано: (2016)
• Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML).
  за авторством: Goodyear, O, та інші
  Опубліковано: (2012)